Related Experiment Video
Updated: Jan 11, 2026

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience
Daniele Mengato1, Laura Camuffo1, Federica Todino1
1Hospital Pharmacy Unit, Azienda Ospedale-Università Padova, Padua, Italy.
Introduction:
Clinical pharmacy services contribute to safer and more effective medication use, yet remain underdeveloped in several countries, including Italy, due to limited recognition and funding. Local initiatives are essential to demonstrate feasibility and impact.
Objective:
To describe the 2-year implementation of a Clinical Pharmacy Ambulatory (CPA) in a large Italian tertiary hospital, and to evaluate its contribution to medication management, adherence, and interprofessional collaboration.
Methods:
The CPA was established within the Hospital Pharmacy Department of the Azienda Ospedale-Università di Padova. It provided three pharmacist-led services: best possible medication history (BPMH), medication review (MR), and patient education programs (PEPs). Services were delivered on-site and through telepharmacy, integrated into the electronic medical record. Outcomes were assessed using key performance indicators, including service volumes, fulfillment rates, acceptance of recommendations, and adherence measures. A survey of healthcare professionals assessed changes in perception of pharmacists' role.
Results:
Over 2 years, the CPA served more than 2,200 patients. BPMH activity increased by 12%, with fulfillment consistently above 97%. Fifty-one medication reviews generated 670 therapeutic recommendations, with high physician acceptance (over 70%). PEPs enrolled 151 patients, achieving excellent adherence outcomes. Surveys showed improved awareness of the pharmacist's role and stronger support for their integration into multidisciplinary care.
Conclusion:
The CPA represents the first structured pharmacist-led ambulatory formally described in Italy. It demonstrates feasibility, clinical relevance, and organizational value in a healthcare system where clinical pharmacy is not yet institutionalized. This model may inform broader adoption of pharmacist-led services in countries where clinical pharmacy remains underdeveloped.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Clinical Trials: Overview

